Molecular design and application of splice-switching antibody-oligonucleotide conjugate for hypertrophic cardiomyopathy-related MYBPC3 splice modulation.

Projektinformationen

HCMSpliceAOC

ID Finanzhilfevereinbarung: 101130771

DOI

10.3030/101130771

Projekt abgeschlossen

EK-Unterschriftsdatum 15 Mai 2023

Startdatum 1 Juni 2023

Enddatum 31 Mai 2025

Finanziert unter

• Widening participation and spreading excellence

Gesamtkosten

Keine Daten

EU-Beitrag

€ 156 778,56

Koordiniert durch

FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE
Portugal

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Data Management Plan (1)

Data management plan

The DMP will describe the data that will be acquired or produced during the project; how these data will be managed, described, and stored. Additionally, it will define the standards to be used for both handling and protecting the data ensuring compliance with the FAIR principles. The DMP will define all the aspects of data management during and after the completion of the project. The first version of the DMP will be concluded in month 6 and it will be regularly updated throughout the project.

Documents, reports (1)

Communication, Dissemination & Exploitation Plan

The plan describes the planned measures to maximize the impact of the project, including the dissemination and exploitation measures that are planned, and the target group(s) addressed. Regarding communication measures and public engagement strategy, the aim is to inform and reach out to society and show the activities performed, and the use and the benefits the project will have for citizens.